Spence McClelland joined Noro-Mosely Partners in 2010 and supports the firm’s investments in healthcare, software and tech-enabled services. Spence is focused on reviewing investment opportunities and on working with portfolio company management teams to develop and execute their strategic plans. He currently represents NMP on the board of Diabetes Care Group, and serves as a board observer for Acumen Brands and Wellcentive.
Prior to joining NMP, Spence was a co-founder of RGC Advisors, a search firm in the home health industry. Previously, he worked in the corporate development group of Healthways, Inc., where he was responsible for identifying, evaluating and executing acquisitions and strategic partnerships for the company. In addition, he developed numerous business plans on potential new markets, channels and business models for the company’s solutions. Prior to joining Healthways, Spence was an associate with the private equity firm Willis Stein & Partners, where he supported investment decisions through extensive due diligence and analysis while also assisting portfolio company management teams with strategic planning. He has also held investment banking positions with J.C. Bradford & Co. and DLJ / Credit Suisse First Boston.
Spence received a BA from Vanderbilt University, where he was a member of Phi Beta Kappa, and an MBA with distinction from the Kellogg School of Management at Northwestern University.